Yale Cardiovascular Medicine Grand Rounds: "Treating Dyslipidemia in 2020: Molds, Monoclonals, and mRNA Silencing"
- Understanding efficacy and safety of different lipid lowering.
- Understanding the role of triglyceride -rich lipoproteins therapies.
- Understanding optimal lipid targets for different populations.
Harvard Medical SchoolMarc Sabatine, MDLewis Dexter, MD Distinguished Chair in Cardiovascular Medicine, Professor
Coffee and Tea: Coffee & Tea.